Kamada (KMDA) Change in Acquisitions & Divestments (2013 - 2026)
Kamada (KMDA) posted quarterly Change in Acquisitions & Divestments of -$40.2 million for Q1 2026, down 737.88% on a QoQ basis from $6.3 million in Q1 2023.
Kamada (KMDA) Change in Acquisitions & Divestments (2013 - 2026) Analysis & Trends
Kamada (KMDA) has reported Change in Acquisitions & Divestments for 12 consecutive years, with -$40.2 million the latest figure, recorded in Q1 2026.
- Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to -$40.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$20.4 million (changed N/A YoY) and the FY2022 annual result came in at $7.6 million, down 80.55% from the prior year.
- Change in Acquisitions & Divestments retreated to -$40.2 million in Q1 2026 per KMDA's latest filing, from $6.3 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for KMDA reached as high as $13.5 million in Q1 2022 and fell as low as -$40.2 million in Q1 2026.
- A 3-year average of -$6.8 million and a median of $6.3 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
- Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments surged 249.91% — and 2023, when it sank 53.26%.
- Year by year, Change in Acquisitions & Divestments stood at $13.5 million in 2022, then plunged by 53.26% to $6.3 million in 2023, then sank by 737.88% to -$40.2 million in 2026.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered -$40.2 million, $6.3 million, and $13.5 million for Q1 2026, Q1 2023, and Q1 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.23 Mn |
| Mar 31, 2026 | -40.23 Mn |
| Mar 31, 2023 | 6.31 Mn |
| Mar 31, 2023 | 6.31 Mn |
| Mar 31, 2022 | 13.49 Mn |
| Mar 31, 2022 | 13.49 Mn |
| Sep 30, 2021 | 36.12 Mn |
| Sep 30, 2021 | 36.12 Mn |
| Jun 30, 2021 | 11.97 Mn |
| Jun 30, 2021 | 11.97 Mn |
| Mar 31, 2021 | -9.00 Mn |
| Mar 31, 2021 | -9.00 Mn |
| Dec 31, 2020 | 8.00 Mn |
| Dec 31, 2020 | 8.00 Mn |
| Sep 30, 2020 | -31.29 Mn |
| Sep 30, 2020 | -31.29 Mn |
| Mar 31, 2020 | 15.65 Mn |
| Mar 31, 2020 | 15.65 Mn |
| Dec 31, 2019 | 7.89 Mn |
| Dec 31, 2019 | 7.89 Mn |